Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-08

Clinical Trial Update: A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1-2 trial studying cetuximab with oxaliplatin, capecitabine, and radiation followed by surgery for locally-advanced rectal cancer. The trial was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Cetuximab (cetuximab)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: George Albert Fisher | Conditions: Rectal Cancer, Colo-rectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-12-08